|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Rangarajan B, Shet T, Wadasadawala T, Nair
NS, Sairam RM, Hingmire SS and Bajpai J: Breast cancer: An overview
of published Indian data. South Asian J Cancer. 5:86–92. 2016.
View Article : Google Scholar :
|
|
3
|
Onyido EK, Sweeney E and Nateri AS:
Wnt-signalling pathways and microRNAs network in carcinogenesis:
Experimental and bioinformatics approaches. Mol Cancer. 15:562016.
View Article : Google Scholar :
|
|
4
|
Cheng W, Yan K, Xie LY, Chen F, Yu HC,
Huang YX and Dang CX: MiR-143-3p controls TGF-β1-induced cell
proliferation and extracellular matrix production in airway smooth
muscle via negative regulation of the nuclear factor of activated T
cells 1. Mol Immunol. 78:133–139. 2016. View Article : Google Scholar
|
|
5
|
Sun X, Li Y, Zheng M, Zuo W and Zheng W:
MicroRNA-223 increases the sensitivity of triple-negative breast
cancer stem cells to TRAIL-induced apoptosis by targeting HAX-1.
PLoS One. 11:e01627542016. View Article : Google Scholar :
|
|
6
|
Ma L: MicroRNA and metastasis. Adv Cancer
Res. 132:165–207. 2016. View Article : Google Scholar
|
|
7
|
Zhang Z, Zhang M, Chen Q and Zhang Q:
Downregulation of microRNA-145 promotes epithelial-mesenchymal
transition via regulating Snail in osteosarcoma. Cancer Gene Ther.
24:83–88. 2017. View Article : Google Scholar
|
|
8
|
Del Rosario RC, Damasco JR and Aguda BD:
MicroRNA inhibition fine-tunes and provides robustness to the
restriction point switch of the cell cycle. Sci Rep. 6:328232016.
View Article : Google Scholar :
|
|
9
|
Chiu LY, Kishnani PS, Chuang TP, Tang CY,
Liu CY, Bali D, Koeberl D, Austin S, Boyette K, Weinstein DA, et
al: Identification of differentially expressed microRNAs in human
hepatocellular adenoma associated with type I glycogen storage
disease: A potential utility as biomarkers. J Gastroenterol.
49:1274–1284. 2014. View Article : Google Scholar
|
|
10
|
Wong N, Khwaja SS, Baker CM, Gay HA,
Thorstad WL, Daly MD, Lewis JS Jr and Wang X: Prognostic microRNA
signatures derived from The cancer genome atlas for head and neck
squamous cell carcinomas. Cancer Med. 5:1619–1628. 2016. View Article : Google Scholar :
|
|
11
|
Cheng CM, Shiah SG, Huang CC, Hsiao JR and
Chang JY: Up-regulation of miR-455-5p by the TGF-β-SMAD signalling
axis promotes the proliferation of oral squamous cancer cells by
targeting UBE2B. J Pathol. 240:38–49. 2016. View Article : Google Scholar
|
|
12
|
Dong Y, He D, Peng Z, Peng W, Shi W, Wang
J, Li B, Zhang C and Duan C: Circular RNAs in cancer: An emerging
key player. J Hematol Oncol. 10:22017. View Article : Google Scholar :
|
|
13
|
Liu J, Zhang J, Li Y, Wang L, Sui B and
Dai D: MiR-455-5p acts as a novel tumor suppressor in gastric
cancer by down-regulating RAB18. Gene. 592:308–315. 2016.
View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Lei L, Wang X and Chen Z: PET/CT imaging
for monitoring recurrence and evaluating response to treatment in
breast cancer. Adv Clin Exp Med. 25:377–382. 2016. View Article : Google Scholar
|
|
16
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
17
|
Huan L, Liang LH and He XH: Role of
microRNAs in inflammation-associated liver cancer. Cancer Biol Med.
13:407–425. 2016. View Article : Google Scholar :
|
|
18
|
Nagini S: Breast cancer: Current molecular
therapeutic targets and new players. Anticancer Agents Med Chem.
17:152–163. 2017. View Article : Google Scholar
|
|
19
|
Zhao H, Kang X, Xia X, Wo L, Gu X, Hu Y,
Xie X, Chang H, Lou L and Shen X: miR-145 suppresses breast cancer
cell migration by targeting FSCN-1 and inhibiting
epithelial-mesenchymal transition. Am J Transl Res. 8:3106–3114.
2016.
|
|
20
|
Zhang F, Wang B, Long H, Yu J, Li F, Hou H
and Yang Q: Decreased miR-124-3p expression prompted breast cancer
cell progression mainly by targeting beclin-1. Clin Lab.
62:1139–1145. 2016. View Article : Google Scholar
|
|
21
|
Wu J, Yuan P, Mao Q, Lu P, Xie T, Yang H
and Wang C: miR-613 inhibits proliferation and invasion of breast
cancer cell via VEGFA. Biochem Biophys Res Commun. 478:274–278.
2016. View Article : Google Scholar
|
|
22
|
Shoshan E, Mobley AK, Braeuer RR, Kamiya
T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, et al:
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma
growth and metastasis. Nat Cell Biol. 17:311–321. 2015. View Article : Google Scholar :
|
|
23
|
Zhang DH, Yang ZL, Zhou EX, Miao XY, Zou
Q, Li JH, Liang LF, Zeng GX and Chen SL: Overexpression of Thy1 and
ITGA6 is associated with invasion, metastasis and poor prognosis in
human gallbladder carcinoma. Oncol Lett. 12:5136–5144. 2016.
|
|
24
|
Zhang XF, Liu T, Li Y and Li S:
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of
poor prognosis in patients with breast cancer. Int J Clin Exp
Pathol. 8:9440–9445. 2015.
|
|
25
|
Li C, Deng L, Zhi Q, Meng Q, Qian A, Sang
H, Li X and Xia J: MicroRNA-183 functions as an oncogene by
regulating PDCD4 in gastric cancer. Anticancer Agents Med Chem.
16:447–455. 2016. View Article : Google Scholar
|
|
26
|
Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei
WI, Ho WK and Wong TS: MicroRNA 744-3p promotes MMP-9-mediated
metastasis by simultaneously suppressing PDCD4 and PTEN in
laryngeal squamous cell carcinoma. Oncotarget. 7:58218–58233. 2016.
View Article : Google Scholar :
|
|
27
|
Li Y, Jiang D, Zhang Q, Liu X and Cai Z:
Ubiquitin-specific protease 4 inhibits breast cancer cell growth
through the upregulation of PDCD4. Int J Mol Med. 38:803–811. 2016.
View Article : Google Scholar :
|
|
28
|
Cheng Y, Xiang G, Meng Y and Dong R:
MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in
human breast cancer by targeting the PDCD4. Reprod Biol.
16:225–233. 2016. View Article : Google Scholar
|
|
29
|
Venturutti L, Romero LV, Urtreger AJ,
Chervo MF, Russo Cordo RI, Mercogliano MF, Inurrigarro G, Pereyra
MG, Proietti CJ, Izzo F, et al: Stat3 regulates ErbB-2 expression
and co-opts ErbB-2 nuclear function to induce miR-21 expression,
PDCD4 downregulation and breast cancer metastasis. Oncogene.
35:2208–2222. 2016. View Article : Google Scholar
|
